المؤلفون: Taya M; Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA., Hou X; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Veneris JT; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL, USA., Kazi N; Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA., Larson MC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Maurer MJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Heinzen EP; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA., Chen H; Department of Pathology, UT Southwestern, Dallas, TX, USA., Lastra R; Department of Pathology, The University of Chicago, Chicago, IL, USA., Oberg AL; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Weroha SJ; Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Fleming GF; Department of Medicine, Section of Hematology and Oncology, The University of Chicago, Chicago, IL, USA., Conzen SD; Division of Hematology and Oncology, UT Southwestern, Dallas, TX, USA. suzanne.conzen@utsouthwestern.edu.

المصدر: Journal of gynecologic oncology [J Gynecol Oncol] 2024 Jun 14. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-0399 (Electronic) Linking ISSN: 20050380 NLM ISO Abbreviation: J Gynecol Oncol Subsets: MEDLINE

المؤلفون: Veneris JT; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States of America; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, United States of America. Electronic address: Jennifer_Veneris@dfci.harvard.edu., Mahajan P; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States of America; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, United States of America., Frazier AL; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Department of Pediatrics, Section of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States of America; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, United States of America.

المصدر: Gynecologic oncology [Gynecol Oncol] 2020 Aug; Vol. 158 (2), pp. 467-475. Date of Electronic Publication: 2020 Jun 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Germ Cell and Embryonal/*diagnosis , Neoplasms, Germ Cell and Embryonal/*therapy , Ovarian Neoplasms/*diagnosis , Ovarian Neoplasms/*therapy, Clinical Trials, Phase III as Topic ; Female ; Humans ; Randomized Controlled Trials as Topic ; Teratoma/diagnosis ; Teratoma/therapy

SCR Disease Name: Teratoma, Ovarian

المؤلفون: Veneris JT; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. Electronic address: Jennifer_Veneris@dfci.harvard.edu., Matulonis UA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Liu JF; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Konstantinopoulos PA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.

المصدر: Gynecologic oncology [Gynecol Oncol] 2020 Feb; Vol. 156 (2), pp. 488-497. Date of Electronic Publication: 2019 Oct 17.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Ovarian Neoplasms/*drug therapy , Ovarian Neoplasms/*immunology , Poly(ADP-ribose) Polymerase Inhibitors/*administration & dosage, Animals ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; DNA Repair ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Germ-Line Mutation ; Humans ; Ovarian Neoplasms/genetics ; Randomized Controlled Trials as Topic

المؤلفون: Veneris JT; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: Jennifer_Veneris@dfci.harvard.edu., Lee EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Goebel EA; Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States of America., Nucci MR; Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Lindeman N; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Horowitz NS; Gynecologic Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Lee L; Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Raut CP; Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, United States; Harvard Medical School, Boston, MA, United States of America., Crotzer D; Gynecologic Oncology, Nebraska Methodist Hospital, Omaha, NE, United States of America., Matulonis U; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Konstantinopoulos PA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Campos S; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.

المصدر: Gynecologic oncology [Gynecol Oncol] 2019 Jun; Vol. 153 (3), pp. 471-478. Date of Electronic Publication: 2019 Mar 29.

نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol

مواضيع طبية MeSH: Adenocarcinoma/*genetics , Adenocarcinoma/*therapy , DNA Polymerase II/*genetics , Endometrial Neoplasms/*genetics , Pancreatic Neoplasms/*therapy , Poly-ADP-Ribose Binding Proteins/*genetics , Stomach Neoplasms/*therapy, Adenocarcinoma/diagnosis ; Adenocarcinoma/secondary ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols ; Carboplatin/administration & dosage ; Endometrial Neoplasms/pathology ; Endometrial Neoplasms/therapy ; Female ; Humans ; Middle Aged ; Mutation ; Omentum/surgery ; Paclitaxel/administration & dosage ; Pancreatic Neoplasms/diagnosis ; Pancreatic Neoplasms/secondary ; Stomach Neoplasms/diagnosis ; Stomach Neoplasms/genetics ; Stomach Neoplasms/secondary

المؤلفون: Veneris JT; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA Jennifer_Veneris@dfci.harvard.edu., Huang L; Center for Research Informatics, The University of Chicago, Chicago, Illinois, USA., Churpek JE; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA.; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA., Conzen SD; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA.; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA.; Ben May Department for Cancer Biology, The University of Chicago, Chicago, Illinois, USA., Fleming GF; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, Illinois, USA.; The University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2019 Feb; Vol. 29 (2), pp. 357-364. Date of Electronic Publication: 2019 Jan 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Tangen IL; Department of Gynaecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Veneris JT; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL, United States., Halle MK; Department of Gynaecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Werner HM; Department of Gynaecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Trovik J; Department of Gynaecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Akslen LA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway., Salvesen HB; Department of Gynaecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Conzen SD; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL, United States; Ben May Department of Cancer Biology, The University of Chicago, Chicago, IL, United States; The University of Chicago Comprehensive Cancer Center, Chicago, IL, United States., Fleming GF; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL, United States; The University of Chicago Comprehensive Cancer Center, Chicago, IL, United States., Krakstad C; Department of Gynaecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway. Electronic address: camilla.krakstad@uib.no.

المصدر: Gynecologic oncology [Gynecol Oncol] 2017 Dec; Vol. 147 (3), pp. 672-677. Date of Electronic Publication: 2017 Sep 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Endometrial Neoplasms/*metabolism , Endometrial Neoplasms/*pathology , Receptors, Glucocorticoid/*biosynthesis, Aged ; Disease Progression ; Endometrial Neoplasms/genetics ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; Transcriptome

المؤلفون: Veneris JT; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL, United States. Electronic address: jveneris@medicine.bsd.uchicago.edu., Darcy KM; Women's Health Integrated Research Center, Inova Health System, Annandale, VA, United States., Mhawech-Fauceglia P; Department of Pathology, University of Southern California, Los Angeles, CA, United States., Tian C; Women's Health Integrated Research Center, Inova Health System, Annandale, VA, United States., Lengyel E; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, The University of Chicago, Chicago, IL, United States; The University of Chicago Comprehensive Cancer Center, Chicago, IL, United States., Lastra RR; Department of Pathology, The University of Chicago, Chicago, IL, United States., Pejovic T; Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Oregon Health & Science University, Portland, OR, United States., Conzen SD; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL, United States; Ben May Department for Cancer Biology, The University of Chicago, Chicago, IL, United States; The University of Chicago Comprehensive Cancer Center, Chicago, IL, United States., Fleming GF; Department of Medicine, Section of Hematology-Oncology, The University of Chicago, Chicago, IL, United States; The University of Chicago Comprehensive Cancer Center, Chicago, IL, United States. Electronic address: gfleming@medicine.bsd.uchicago.edu.

المصدر: Gynecologic oncology [Gynecol Oncol] 2017 Jul; Vol. 146 (1), pp. 153-160. Date of Electronic Publication: 2017 Apr 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Glandular and Epithelial/*metabolism , Ovarian Neoplasms/*metabolism , Receptors, Glucocorticoid/*biosynthesis, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Ovarian Epithelial ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Neoplasms, Glandular and Epithelial/drug therapy ; Neoplasms, Glandular and Epithelial/pathology ; Neoplasms, Glandular and Epithelial/surgery ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/surgery ; Prognosis ; Survival Rate ; Young Adult

المؤلفون: Krishnan V; The Section of Urology, Department of Surgery, The University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA., Stadick N, Clark R, Bainer R, Veneris JT, Khan S, Drew A, Rinker-Schaeffer C

المصدر: Cancer metastasis reviews [Cancer Metastasis Rev] 2012 Dec; Vol. 31 (3-4), pp. 605-13.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8605731 Publication Model: Print Cited Medium: Internet ISSN: 1573-7233 (Electronic) Linking ISSN: 01677659 NLM ISO Abbreviation: Cancer Metastasis Rev Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*, MAP Kinase Kinase 4/*physiology , Neoplasm Metastasis/*prevention & control , Tumor Suppressor Proteins/*physiology, Animals ; Female ; Humans ; Neoplasm Metastasis/pathology ; Ovarian Neoplasms/pathology

المؤلفون: Bainer RO; Department of Human Genetics, The University of Chicago, Chicago, IL, USA., Veneris JT; The Committee on Cancer Biology, The University of Chicago, Chicago, IL, USA., Yamada SD; Department of Obstetrics and Gynecology, The University of Chicago, Chicago, IL, USA., Montag A; Department of Pathology, The University of Chicago, Chicago, IL, USA., Lingen MW; Department of Pathology, The University of Chicago, Chicago, IL, USA., Gilad Y; Department of Human Genetics, The University of Chicago, Chicago, IL, USA., Rinker-Schaeffer CW; The Committee on Cancer Biology, The University of Chicago, Chicago, IL, USA.

المصدر: Clinical & experimental metastasis [Clin Exp Metastasis] 2012 Jun; Vol. 29 (5), pp. 397-408. Date of Electronic Publication: 2012 Feb 21.

نوع المنشور: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Profiling*, Biomarkers, Tumor/*genetics , MAP Kinase Kinase 4/*genetics , MAP Kinase Kinase 4/*metabolism , Omentum/*pathology , Ovarian Neoplasms/*enzymology , Ovarian Neoplasms/*genetics, Animals ; Biomarkers, Tumor/metabolism ; Blotting, Western ; Female ; Humans ; Immunoenzyme Techniques ; Mice ; Oligonucleotide Array Sequence Analysis ; Omentum/metabolism ; Ovarian Neoplasms/secondary ; RNA, Messenger/genetics ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Time Factors ; Tumor Cells, Cultured ; Tumor Stem Cell Assay